Akthelia Pharmaceuticals
leading the science of our surfaces
Akthelia Pharmaceuticals is a biotech company in Reykjavík, Iceland.
- Headquarters
- Reykjavík
- Website
- aktheliapharma.com
About
Akthelia Pharmaceuticals develops host-directed therapies targeting mucosal barrier injury, with a primary focus on gastrointestinal mucositis in oncology. Its therapeutic approach mimics and enhances natural metabolites released by microbiota. Candidate molecules are designed to enhance epithelial immune status and restore barrier function.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
- Cloud/Infrastructure ×1
- Frontend ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/akthelia-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/akthelia-pharmaceuticals" alt="Akthelia Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>

